This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ – New Privacy Policy
Merck CEO Robert Davis joins ‘Mornings with Maria’ to discuss the new $1 billion biologics manufacturing facility slated to be built in Wilmington, Delaware, and bringing manufacturing back to the U.S.
Thousands of jobs could be on the horizon for American workers as drug manufacturer Merck takes steps to move manufacturing into the U.S., particularly in the form of a $1 billion state-of-the-art biologics center under construction in Wilmington, Delaware.
In a FOX Business exclusive, company CEO Robert Davis told “Mornings with Maria” the effort will take time as Merck builds the capability, but the payoff could mean stable access to drugs in addition to high-paying jobs.
Davis said Merck currently does contract manufacturing for the drug substance in the U.S. as well as outside the U.S. but the company is looking to have both substance and product in the U.S.
MAN FROM INDIA ARRESTED IN TEXAS FOR ALLEGEDLY SELLING FAKE CANCER TREATMENT DRUGS TO PEOPLE IN US
Signage outside Merck headquarters in Kenilworth, New Jersey, U.S., on Monday, Jan. 25, 2021. (Christopher Occhicone/Bloomberg / Getty Images)
“For Ireland, what that means is not necessarily that we’re going to close down operations, because we still have to serve the rest of the world, too,” he explained on Tuesday.
“This is really an opportunity for us to [have the] U.S. [provide] for [the] U.S., [and] Europe [provide] for Europe, and have a much more risk-mitigated, resilient supply chain that has optionality that allows us to bring security. And as we think about national security, this is important security to the drug supply in the United States so that we can ensure that no matter what the situation is, U.S. patients get access to medicine.”
HOW TRUMP’S TARIFFS COULD IMPACT THE LABOR MARKET
Merck makes popular drugs such as Keytruda, an immunotherapy drug used for cancer medicine (Lindsey Nicholson/UCG/Universal Images Group via Getty Images/Getty Images)
A press release from the corporate states that Merck Wilmington Biotech “will come with laboratory, production, and warehouse functions to enable launch production and advertising of next-generation biological and therapeutics, adding potent antibody conjugates (ADCs), concentrating on construction, and diversifying its pipeline. “
It will also have production functions for the popular immunotherapy drug Keytruda, which is used to treat cancer.
Click here to put Fox on the march
President Trump accused Ireland of luring U. S. pharmaceutical companies, taking the U. S. source of income and jobs from the U. S. U. S. Due to its low corporate tax rate.
Davis said the location may be the first to supply 4,000 structure jobs and 500 full-time positions, but expand to a staff of 2,000 with 30,000 structure workers.
“This will be an opportunity for tradespeople and production to have good, high-quality, well-paying jobs here in the United States,” he added.
This curtain would possibly not be published, broadcast, rewritten, or redistributed. © 2025 Fox News Network, LLC. All Rights Reserved. Frequently Asked Questions – New Privacy Policy